Anand Bhaskar has filed 8 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 30000 shares of Summit Therapeutics Inc. ($SMMT) on January 08, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 8, 2026 | Summit Therapeutics Inc. | $SMMT | Anand Bhaskar | Chief Accounting Officer | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 744,442,538 | 9999.99% | 0.00% |
| Oct. 21, 2025 | Summit Therapeutics Inc. | $SMMT | Anand Bhaskar | Chief Accounting Officer | A | Common Stock | 26680 | $18.74 | 159,751.0000 | 744,442,538 | 20.05% | 0.00% |
| Sept. 18, 2025 | Summit Therapeutics Inc. | $SMMT | Anand Bhaskar | Chief Accounting Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 737,679,704 | 9999.99% | 0.01% |
| April 29, 2025 | Summit Therapeutics Inc. | $SMMT | Anand Bhaskar | Chief Accounting Officer | A | Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 737,679,704 | 9999.99% | 0.08% |
| April 29, 2025 | Summit Therapeutics Inc. | $SMMT | Anand Bhaskar | Chief Accounting Officer | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 737,679,704 | 9999.99% | 0.01% |
| Jan. 12, 2025 | Summit Therapeutics Inc. | $SMMT | Anand Bhaskar | Chief Accounting Officer | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2024 | Summit Therapeutics Inc. | $SMMT | Anand Bhaskar | Chief Accounting Officer | A | Common Stock | 22026 | $22.70 | 131,426.0000 | 0 | 20.13% | 0.00% |
| April 2, 2024 | Summit Therapeutics Inc. | $SMMT | Anand Bhaskar | Chief Accounting Officer | A | Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |